Literature DB >> 8162659

Polypharmacy. Pharmacokinetic perspectives.

P K Honig1, L R Cantilena.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8162659     DOI： 10.2165/00003088-199426020-00001

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  35 in total

Review 1.  Over-the-counter medications in cardiac transplant recipients: guidelines for use.

Authors:  K D Lake; J G Nolen; R A Slaker; T J Reutzel; S K Milfred; D F Solbrack; F M Hoffman
Journal:  Ann Pharmacother       Date:  1992-12       Impact factor: 3.154

2.  Increased gastric pH and the bioavailability of fluconazole and ketoconazole.

Authors:  R A Blum; D T D'Andrea; B M Florentino; J H Wilton; D M Hilligoss; M J Gardner; E B Henry; H Goldstein; J J Schentag
Journal:  Ann Intern Med       Date:  1991-05-01       Impact factor: 25.391

Review 3.  Alternative therapies, 1990. An overview.

Authors:  L S McGinnis
Journal:  Cancer       Date:  1991-03-15       Impact factor: 6.860

4.  Polypharmacy in psychiatry: three case studies and methods for prevention.

Authors:  R B Stewart; K C Yedinak; M R Ware
Journal:  Ann Pharmacother       Date:  1992-04       Impact factor: 3.154

5.  The ageing society.

Authors:  W J MacLennan
Journal:  Br J Hosp Med       Date:  1988-02

6.  Predictors of physician prescribing change in an educational experiment to improve medication use.

Authors:  S B Soumerai; J Avorn
Journal:  Med Care       Date:  1987-03       Impact factor: 2.983

7.  Letter: Diuretics during lithium therapy.

Authors:  S MacNeil; E Hanson-Nortey; C Paschalis; P R Eastwood; F A Jenner
Journal:  Lancet       Date:  1975-06-07       Impact factor: 79.321

8.  Phenylbutazone-warfarin interaction in man: further stereochemical and metabolic considerations.

Authors:  C Banfield; R O'Reilly; E Chan; M Rowland
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

9.  Heterogeneity of CYP3A isoforms metabolizing erythromycin and cortisol.

Authors:  C M Hunt; P B Watkins; P Saenger; G M Stave; N Barlascini; C O Watlington; J T Wright; P S Guzelian
Journal:  Clin Pharmacol Ther       Date:  1992-01       Impact factor: 6.875

Review 10.  Clinical pharmacokinetic considerations in the elderly. An update.

Authors:  S Dawling; P Crome
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447
View more
  6 in total

Review 1.  Benefits and risks of self medication.

Authors:  C M Hughes; J C McElnay; G F Fleming
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  Societal perspectives on the role of community pharmacists and over-the-counter drugs in Jordan.

Authors:  Mayyada Wazaify; Abla Al-Bsoul-Younes; Eman Abu-Gharbieh; Linda Tahaineh
Journal:  Pharm World Sci       Date:  2008-08-06

3.  Clinical significance of pharmacokinetic drug interactions with over-the-counter (OTC) drugs.

Authors:  P K Honig; B K Gillespie
Journal:  Clin Pharmacokinet       Date:  1998-09       Impact factor: 6.447

Review 4.  Drug interactions between prescribed and over-the-counter medication.

Authors:  P K Honig; B K Gillespie
Journal:  Drug Saf       Date:  1995-11       Impact factor: 5.606

5.  Delirium and extrapyramidal symptoms due to a lithium-olanzapine combination therapy: a case report.

Authors:  Cengiz Tuglu; Esin Erdogan; Ercan Abay
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

6.  Patient-related risk factors for self-reported medication errors in hospital and community settings in 8 countries.

Authors:  Kim Sears; Andrea Scobie; Neil J Mackinnon
Journal:  Can Pharm J (Ott)       Date:  2012-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.